An Approach to Treat Conundrum of Skin Cancer: Bioactive Loaded
Niosomes

Shikha      Srivastava; Divya      Sharma

doi:10.2174/1574885518666230209150126

Abstract

Background: Skin cancer is one of the most life-threatening and progressive diseases nowadays, majorly resulting from the cumulative effect of genetic and environmental exposure including UV rays and numerous pollutants. UV radiation stimulates the excessive generation of Reactive oxygen species (ROS) and Reactive nitrogen species (RNS), altering numerous signaling and inflammatory pathways and cumulatively causing alteration at numerous genetic and inflammatory levels. Numerous treatment strategies have been proposed for this purpose, and it has been found that antioxidants could play a crucial role in regulating inflammation at certain levels. Among numerous treatment strategies, natural flavonoid quercetin could play a vital role in protecting cells from oxidative stress as it is enriched with anticancer, antioxidant, and anti-inflammatory properties. The activities of quercetin could be further enhanced by administrating it through novel systems.

Objective: Thus, the present article focuses on the delivery of natural flavonoid quercetin via novel carrier noisome to enhance targeting potency and safety efficacy.

Method: Optimized quercetin-loaded niosomes were prepared by mechanical shaking method followed by solvent evaporation and altering the ratio of cholesterol and span 80. In vitro characterization was performed for morphology, zeta potential (ZP), entrapment efficiency and drug release.

Result: The optimized niosome was reported to have a size range of 120 nm, entrapment efficiency (80%-85%) and followed zero order kinetics.

Conclusion: Optimized quercetin-loaded niosomes were successfully formulated and characterized for controlled drug delivery.

« Previous Next »

Graphical Abstract

[1]
Rodríguez S, Arenas M, Gutierrez C, et al. Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy. Clin Transl Oncol  2018; 20(4): 431-42.
 [http://dx.doi.org/10.1007/s12094-017-1733-z] [PMID: 28808925]

[2]
Narendhirakannan RT, Hannah MAC. Oxidative stress and skin cancer: an overview. Indian J Clin Biochem  2013; 28(2): 110-5.
 [http://dx.doi.org/10.1007/s12291-012-0278-8] [PMID: 24426195]

[3]
Buchanan Lunsford N, Berktold J, Holman DM, Stein K, Prempeh A, Yerkes A. Skin cancer knowledge, awareness, beliefs and preventive behaviors among black and hispanic men and women. Prev Med Rep  2018; 12: 203-9.
 [http://dx.doi.org/10.1016/j.pmedr.2018.09.017] [PMID: 30364862]

[4]
Xu D, Hu MJ, Wang YQ, Cui YL. Antioxidant activities of quercetin and its complexes for medicinal application. Molecules  2019; 24(6): 1123.
 [http://dx.doi.org/10.3390/molecules24061123] [PMID: 30901869]

[5]
Srivastava NS, Srivastava RAK. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells. Phytomedicine  2019; 52: 117-28.
 [http://dx.doi.org/10.1016/j.phymed.2018.09.224] [PMID: 30599890]

[6]
Park S, Lim W, Bazer FW, Whang KY, Song G. Quercetin inhibits proliferation of endometriosis regulating cyclin D1 and its target microRNAs in vitro and in vivo. J Nutr Biochem  2019; 63: 87-100.
 [http://dx.doi.org/10.1016/j.jnutbio.2018.09.024] [PMID: 30359864]

[7]
Murakami A, Ashida H, Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett  2008; 269(2): 315-25.
 [http://dx.doi.org/10.1016/j.canlet.2008.03.046] [PMID: 18467024]

[8]
Yin Y, Li W, Son YO, et al. Quercitrin protects skin from UVB-induced oxidative damage. Toxicol Appl Pharmacol  2013; 269(2): 89-99.
 [http://dx.doi.org/10.1016/j.taap.2013.03.015] [PMID: 23545178]

[9]
Pippa N, Naziris N, Stellas D, et al. PEO-b-PCL grafted niosomes: The cooperativilty of amphiphilic components and their properties in vitro and in vivo. Colloids Surf B Biointerfaces  2019; 177: 338-45.
 [http://dx.doi.org/10.1016/j.colsurfb.2019.01.036] [PMID: 30772668]

[10]
Sandeep KS. Span-60 niosomal oral suspension of fluconazole: formulation and in vitro evaluation Asian J Pharm Res Health Care  2009; 1(2).

[11]
Kumar YP, Kumar KV, Shekar RR, Ravi M, Kishore VS. Formulation and evaluation of econazole niosomes. Sch Acad J Pharm  2013; 2(4): 315-8.

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1574885518666230209150126	Print ISSN 1574-8855
Publisher Name Bentham Science Publisher	Online ISSN 2212-3903

Current Drug Therapy

An Approach to Treat Conundrum of Skin Cancer: Bioactive Loaded Niosomes

Abstract Play Pause

Graphical Abstract

Abstract